| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.6 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.6 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |